Table 1 Self-assessment prior (T0) and post (T1) intervention
Item | T0 | T1 | p-Value | |
|---|---|---|---|---|
Anatomy of the cranio-facial area | SGT | 3.36 | 3.08 | 0.075 (M) |
VP | 3.24 | 3.21 | 0.833 (M) | |
p-Value | 0.49 | 0.58 | ||
Clinical signs of a mandibular fracture | SGT | 4 | 2.92 | <.001 (M) |
VP | 3.94 | 2.91 | <.0001 (M) | |
p-Value | 0.94 | 0.96 | ||
Diagnostic approach of mandibular fractures | SGT | 4.24 | 2.88 | <.0001 (M) |
VP | 4.35 | 3.03 | <.0001 (M) | |
p-Value | 0.37 | 0.54 | ||
Therapy of mandibular fractures | SGT | 4.2 | 2.92 | <.0001 (M) |
VP | 4.26 | 3.03 | <.0001 (M) | |
p-Value | 0.58 | 0.60 | ||
Diagnostic approach of midfacial fractures | SGT | 4.52 | 3.08 | <.0001 (M) |
VP | 4.68 | 3.12 | <.0001 (M) | |
p-Value | 0.303 | 0.936 | ||
Therapy of midfacial fractures | SGT | 4.6 | 3.12 | <.0001 (M) |
VP | 4.62 | 3.29 | <.0001 (M) | |
p-Value | 0.624 | 0.502 | ||
Clinical signs of oro-facial infections | SGT | 4.04 | 3.08 | <.001 (M) |
VP | 4.06 | 2.74 | <.0001 (M) | |
p-Value | 0.904 | 0.118 | ||
Diagnostic approach of oro-facial infections | SGT | 4.32 | 3.2 | <.001 (M) |
VP | 4.41 | 2.97 | <.0001 (M) | |
p-Value | 0.659 | 0.271 | ||
Therapy of oro-facial infections | SGT | 4.28 | 3.04 | <.001 (M) |
VP | 4.50 | 3.00 | <.0001 (M) | |
p-Value | 0.406 | 0.771 | ||
Risk factors for the development of malignant head and neck tumors | SGT | 3.88 | 2.96 | <.001 (M) |
VP | 3.85 | 2.94 | <.001 (M) | |
p-Value | 0.992 | 0.880 | ||
Clinical signs of malignant head and neck tumours | SGT | 4.16 | 3 | <.001 (M) |
VP | 4.24 | 2.97 | <.0001 (M) | |
p-Value | 0.631 | 0.825 | ||
Diagnostic approach of malignant head and neck tumours | SGT | 4.16 | 3.12 | <.001 |
VP | 4.32 | 3.15 | <.0001 | |
p-Value | 0.555 | 0.857 | ||
Therapy of malignant head and neck tumours | SGT | 4.28 | 3.28 | <.001 |
VP | 4.56 | 3.15 | <.0001 | |
p-Value | 0.347 | 0.610 |